SlideShare a Scribd company logo
Pathogenesis of HIT
                                      Heparan sulfate   B-lymphocyte    Heparin
                              Endothelial cell
                                                                                             Resting platelet



                                                                                                      GpIIb/ IIIa


                                             HIT antibody



                                                                                                        PF4



                                                                                                  Fc receptor
Endothelial cell activation




                                                                       Microparticles




                                                            Monocyte                                   Fibrinogen




                                                            Thrombin                    Activated platelet

                                     Tissue factor
Platelet Activation in HIT




Resting Platelet       HIT-activated Platelet

                         Procoagulant, platelet-
                         derived microparticles
Schematic Figure of the Serotonin Release
    Assay (platelet activation assay)




                     Heparin/PF4 Complex
                     HIT-IgG

                     Radiolabeled serotonin
                     released from platelets
Schematic Figure of Solid-phase
  PF4/Heparin-EIA (immunoassay)

                       wash                              wash




Patient serum or plasma is       Add alkaline phosphatase-      Add
added to microtiter plates       conjugated goat                substrate
coated with PF4 and heparin      antihuman IgG
                                                                               COLOR

  heparin                                                        Alkaline phosphatase-
                   PF4/heparin        HIT-IgG
  PF4                                 (from serum or plasma)     conjugated goat
                   complex
                                                                 antihuman IgG
Clinical Features of HIT

Onset                     Typically 5-10 days after starting heparin
                          (<1 day if recent heparin exposure)
Platelet count nadir      Typically 20-150 x 109/L
                          • Median platelet count nadir ~ 60
                          • Sometimes, platelet count falls by >50%, but
                            remains >150
Platelet count recovery   Median time to platelet count >150 = 4 days
                          (90% by 1 week)
Complications             Thromboembolic events: venous > arterial


Incidence of HIT          1%-3% with 1-2 weeks of unfractionated
                          heparin (UFH) prophylaxis post-surgery
Thrombosis Is Common in HIT
                                                           Median platelet count nadir ≈ 60 x 109/L
                              40
Number of Patients With HIT



                                       No HIT-associated
                                       thrombosis
                              30
                                       HIT-associated                      Standard definition
                                       thrombosis                          of thrombocytopenia
                                                                            (150 x 109/L)
                              20




                              10




                              0
                                   3   5     10 15 20 30    50 70 100 150 200 300 500       1000
                                              Platelet Count Nadir (x 109/L)
Economic Consequences of HIT
                                                        *




• A cost analysis model suggests a range of $38,046 to $52,164
  estimated mean hospital cost per patient having HIT
9 Patients With HIT
                               Post-Orthopedic Surgery
                         1000
                                     Patients with HIT (n=9)

                                 *   Unilateral lower-limb DVT                               +2 SD
Platelet Count x 109/L




                         800     **  Bilateral lower-limb DVT
                                  A Arterial clot
                                                                     Normal Postoperative
                                                                        Platelet Counts
                                  PE Pulmonary embolism                  (mean + 2 SD)
                         600
                                                                                             Mean

                         400                                         *                       -2 SD

                                                             **
                         200                                   **
                                                                     PE
                                                                               A        ** *              PE
                                                                                                          PE

                                                                                                       day 17
                           0                                              * *
                                Pre 1   2   3    4   5   6   7   8   9    10       11   12   13   14
                                                  Postoperative Day
HIT Complicating Orthopedic Surgery:
    Platelet Fall >50% Day 4 to 14
                          1000
                                     UFH, n=7
 Platelet Count x 109/L


                                     LMWH, n=2                                                           +2 SD
                                                                                  Normal Postoperative
                          800                                                        Platelet Counts
                                     *DVT                                             (mean + 2 SD)


                          600
                                                               *                                         Mean
                                                                                              *
                          400
                                                                                                         -2 SD

                          200
                                                                                         *              *
                                                                                                        *
                                         150 x 109/L (standard definition of thrombocytopenia)
                            0
                                 Pre 1     2    3    4    5    6    7    8    9     10   11   12   13   14
                                                          Postoperative Day

More Related Content

More from SkyeCreativeMedia (20)

Pptsample1
Pptsample1Pptsample1
Pptsample1
 
Master sample deck
Master sample deckMaster sample deck
Master sample deck
 
Botoxcharts
BotoxchartsBotoxcharts
Botoxcharts
 
Template4
Template4Template4
Template4
 
Template3
Template3Template3
Template3
 
Template2
Template2Template2
Template2
 
Dots template1
Dots template1Dots template1
Dots template1
 
Sample0208 1
Sample0208 1Sample0208 1
Sample0208 1
 
Sample0208 5
Sample0208 5Sample0208 5
Sample0208 5
 
Medical Sample 9
Medical  Sample 9Medical  Sample 9
Medical Sample 9
 
Medical Sample 8
Medical  Sample 8Medical  Sample 8
Medical Sample 8
 
Medical Sample 23
Medical  Sample 23Medical  Sample 23
Medical Sample 23
 
Medical Sample 5
Medical  Sample 5Medical  Sample 5
Medical Sample 5
 
Samp2
Samp2 Samp2
Samp2
 
Samp3
Samp3Samp3
Samp3
 
Samp4
Samp4Samp4
Samp4
 
Samp5
Samp5Samp5
Samp5
 
Samp7
Samp7Samp7
Samp7
 
Medical Sample 10
Medical Sample 10Medical Sample 10
Medical Sample 10
 
Medical Sample 11
Medical Sample 11Medical Sample 11
Medical Sample 11
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 

Medical Sample 13

  • 1. Pathogenesis of HIT Heparan sulfate B-lymphocyte Heparin Endothelial cell Resting platelet GpIIb/ IIIa HIT antibody PF4 Fc receptor Endothelial cell activation Microparticles Monocyte Fibrinogen Thrombin Activated platelet Tissue factor
  • 2. Platelet Activation in HIT Resting Platelet HIT-activated Platelet Procoagulant, platelet- derived microparticles
  • 3. Schematic Figure of the Serotonin Release Assay (platelet activation assay) Heparin/PF4 Complex HIT-IgG Radiolabeled serotonin released from platelets
  • 4. Schematic Figure of Solid-phase PF4/Heparin-EIA (immunoassay) wash wash Patient serum or plasma is Add alkaline phosphatase- Add added to microtiter plates conjugated goat substrate coated with PF4 and heparin antihuman IgG COLOR heparin Alkaline phosphatase- PF4/heparin HIT-IgG PF4 (from serum or plasma) conjugated goat complex antihuman IgG
  • 5. Clinical Features of HIT Onset Typically 5-10 days after starting heparin (<1 day if recent heparin exposure) Platelet count nadir Typically 20-150 x 109/L • Median platelet count nadir ~ 60 • Sometimes, platelet count falls by >50%, but remains >150 Platelet count recovery Median time to platelet count >150 = 4 days (90% by 1 week) Complications Thromboembolic events: venous > arterial Incidence of HIT 1%-3% with 1-2 weeks of unfractionated heparin (UFH) prophylaxis post-surgery
  • 6. Thrombosis Is Common in HIT Median platelet count nadir ≈ 60 x 109/L 40 Number of Patients With HIT No HIT-associated thrombosis 30 HIT-associated Standard definition thrombosis of thrombocytopenia (150 x 109/L) 20 10 0 3 5 10 15 20 30 50 70 100 150 200 300 500 1000 Platelet Count Nadir (x 109/L)
  • 7. Economic Consequences of HIT * • A cost analysis model suggests a range of $38,046 to $52,164 estimated mean hospital cost per patient having HIT
  • 8. 9 Patients With HIT Post-Orthopedic Surgery 1000 Patients with HIT (n=9) * Unilateral lower-limb DVT +2 SD Platelet Count x 109/L 800 ** Bilateral lower-limb DVT A Arterial clot Normal Postoperative Platelet Counts PE Pulmonary embolism (mean + 2 SD) 600 Mean 400 * -2 SD ** 200 ** PE A ** * PE PE day 17 0 * * Pre 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Postoperative Day
  • 9. HIT Complicating Orthopedic Surgery: Platelet Fall >50% Day 4 to 14 1000 UFH, n=7 Platelet Count x 109/L LMWH, n=2 +2 SD Normal Postoperative 800 Platelet Counts *DVT (mean + 2 SD) 600 * Mean * 400 -2 SD 200 * * * 150 x 109/L (standard definition of thrombocytopenia) 0 Pre 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Postoperative Day